REDOX BIOMARKERS
氧化还原生物标志物
基本信息
- 批准号:7975792
- 负责人:
- 金额:$ 10.69万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-04-21 至 2015-03-31
- 项目状态:已结题
- 来源:
- 关键词:Adipose tissueAnimal ModelAortic AneurysmAreaArterial Fatty StreakAtherosclerosisBiochemicalBiological AssayBiological MarkersBiological PreservationBlood VesselsBlood specimenClinicalCollectionConsultationsCore FacilityCryoultramicrotomyDataDiseaseEndothelial CellsEnsureEquipmentEugeniaExperimental DesignsFatty AcidsFoundationsFreezingHumanHuman ResourcesHypochlorous AcidImmunofluorescence ImmunologicImmunofluorescence MicroscopyIndividualInflammationLifeLipoproteinsLow-Density LipoproteinsManualsMeasurementMeasuresMicroscopicModelingMusNonesterified Fatty AcidsObesityOxidation-ReductionOxidative StressOxidative Stress PathwayPeroxidasesPlasmaPreparationProcessProteinsPublicationsPublishingQuality ControlResearch PersonnelResourcesSamplingSerumServicesSpecimenStressSupervisionTechniquesTestingTimeTissue BankingTissue BanksTissue SampleTissuesVascular DiseasesWeightWorkcytokinedesignexperiencehuman tissuein vivomacrophagemolecular imagingnoveloperationprogramsresearch studyvascular inflammation
项目摘要
Core D will provide support for histochemical and immunofluorescence microscopy of vascular and adipose tissues prepared from the various mouse preparations being generated in this Program. Morphological analyses will focus on analyzing tissue markers of vascular inflammation and redox stress using histochemical and immunofluorescence approaches, as well as serum, measurements of cytokines, lipoproteins, and fatty acids. Specific experiments planned with support from Core D are presented in the individual project descriptions.
Core D also will provide centralized collection, processing, and quantitative analysis of biomarkers of oxidative stress and inflammation of tissue specimens for the individual projects. This facility will primarily use histopathological, microscopic, and biochemical approaches. The quantification and characterization of this vascular disease will build on our extensive experience in analysis of both human tissue specimens, particularly atheromata, and Murine models of atherosclerosis, aortic aneurysms, and obesity. During its 15 year life, this core of our program project has built a tissue bank of more than 800 human atherosclerotic specimens preserved for a variety of analytic techniques, and quality controlled. Retrospective quality control of specimens was routinely performed by Eugenia Shvartz under supervision of Dr. Sukhova, according to a
formal manual of operations. Two to four samples per year (1994 - 1999) will be used for quality
immunostaining for macrophages, SMC, and endothelial cells. Recent test revealed perfect preservation and quality of cryosections obtained from 2000 -2006. Protein extracted from tissue samples snap frozen in 2000, 2001, 2004, 2005, and 2007 showed similar yield, 5.5 -11pg/mg of dry weight independently of storage time (- 80¿C). This core will also measure several plasma components integral to the experimental design of the majority of projects. Over its life, this core has supported more than one hundred of publications.
核心D将提供支持该程序中生成的各种小鼠制剂制备的血管和脂肪时序的组织化学和免疫荧光显微镜的支持。形态学分析将使用组织化学和免疫荧光方法以及血清,细胞因子,脂蛋白和脂肪酸的测量,将重点放在分析的血管注射和氧化还原胁迫的组织标记上。在单个项目描述中介绍了在核心D支持下计划的具体实验。
核心D还将对单个项目的氧化应激和组织样本注射的生物标志物进行集中收集,加工和定量分析。该设施将主要使用组织病理学,微观和生化方法。这种血管疾病的定量和表征将基于我们在分析人类组织标本的广泛经验,尤其是动脉粥样硬化,动脉粥样硬化,主动脉动脉瘤和肥胖。在其15年的生命中,我们计划项目的核心已建造了一个组织库,该组织库由800多个人类动脉粥样硬化标本保存,用于各种分析技术和质量控制。根据Sukhova博士的监督,Eugenia Shvartz通常执行标本的回顾性质量控制。
正式手册。每年两到四个样本(1994-1999)将用于质量
巨噬细胞,SMC和内皮细胞的免疫染色。最近的测试表明,从2000年至2006年获得的冷冻切片的完美制备和质量。从组织样品中提取的蛋白质在2000、2001、2004、2005和2007年冻结,表现出相似的产率,即5.5 -11pg/mg干重的干重与存储时间无关(-80?C)。该核心还将测量大多数项目实验设计不可或缺的几个等离子体成分。在其一生中,这个核心支持了一百多个出版物。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Peter Libby其他文献
Peter Libby的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Peter Libby', 18)}}的其他基金
Role of eosinophil cationic proteins in cardiac hypertrophy
嗜酸性粒细胞阳离子蛋白在心脏肥大中的作用
- 批准号:
10735136 - 财政年份:2023
- 资助金额:
$ 10.69万 - 项目类别:
Mechanisms and Modulation of Accelerated Atherosclerosis in Clonal Hematopoiesis
克隆造血加速动脉粥样硬化的机制和调节
- 批准号:
10418315 - 财政年份:2022
- 资助金额:
$ 10.69万 - 项目类别:
Mechanisms and Modulation of Accelerated Atherosclerosis in Clonal Hematopoiesis
克隆造血加速动脉粥样硬化的机制和调节
- 批准号:
10590675 - 财政年份:2022
- 资助金额:
$ 10.69万 - 项目类别:
Novel mechanisms of the thrombotic complications of atherosclerosis
动脉粥样硬化血栓并发症的新机制
- 批准号:
9977702 - 财政年份:2019
- 资助金额:
$ 10.69万 - 项目类别:
Novel mechanisms of the thrombotic complications of atherosclerosis
动脉粥样硬化血栓并发症的新机制
- 批准号:
10191002 - 财政年份:2019
- 资助金额:
$ 10.69万 - 项目类别:
Novel mechanisms of the thrombotic complications of atherosclerosis
动脉粥样硬化血栓并发症的新机制
- 批准号:
10428552 - 财政年份:2019
- 资助金额:
$ 10.69万 - 项目类别:
相似国自然基金
髋关节撞击综合征过度运动及机械刺激动物模型建立与相关致病机制研究
- 批准号:82372496
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
利用碱基编辑器治疗肥厚型心肌病的动物模型研究
- 批准号:82300396
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
利用小型猪模型评价动脉粥样硬化易感基因的作用
- 批准号:32370568
- 批准年份:2023
- 资助金额:50.00 万元
- 项目类别:面上项目
丁苯酞通过调节细胞异常自噬和凋亡来延缓脊髓性肌萎缩症动物模型脊髓运动神经元的丢失
- 批准号:82360332
- 批准年份:2023
- 资助金额:31.00 万元
- 项目类别:地区科学基金项目
APOBEC3A驱动膀胱癌发生发展的动物模型及其机制研究
- 批准号:82303057
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
相似海外基金
Smooth muscle cell PRDM16 and aortic aneurysm
平滑肌细胞PRDM16与主动脉瘤
- 批准号:
10117682 - 财政年份:2021
- 资助金额:
$ 10.69万 - 项目类别:
Smooth muscle cell PRDM16 and aortic aneurysm
平滑肌细胞PRDM16与主动脉瘤
- 批准号:
10456021 - 财政年份:2021
- 资助金额:
$ 10.69万 - 项目类别:
Recurrent laryngeal nerve connective tissues as a factor in vocal fold paralysis
喉返神经结缔组织是声带麻痹的一个因素
- 批准号:
8459463 - 财政年份:2012
- 资助金额:
$ 10.69万 - 项目类别:
Recurrent laryngeal nerve connective tissues as a factor in vocal fold paralysis
喉返神经结缔组织是声带麻痹的一个因素
- 批准号:
8258544 - 财政年份:2012
- 资助金额:
$ 10.69万 - 项目类别:
Recurrent laryngeal nerve connective tissues as a factor in vocal fold paralysis
喉返神经结缔组织是声带麻痹的一个因素
- 批准号:
8827613 - 财政年份:2012
- 资助金额:
$ 10.69万 - 项目类别: